Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii
- PMID: 17324960
- DOI: 10.1093/jac/dkl509
Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii
Abstract
Acinetobacter baumannii is an opportunistic pathogen, causing infections mainly in patients in intensive care units where the extensive use of antimicrobial agents can select for the emergence of multiresistant strains. In fact, since strains resistant to all antimicrobial agents have been reported, A. baumannii is considered the paradigm of multiresistant bacteria. Both acquired and intrinsic resistance can contribute to multiresistance. The ability to acquire multidrug resistance can be due to either the acquisition of genetic elements carrying multiple resistant determinants or mutations affecting the expression of porins and/or efflux pump(s), which can affect unrelated antimicrobial agents. Meanwhile, intrinsic resistance can be generated by the interplay of decreased permeability and constitutive expression of active efflux systems and it too can affect unrelated antimicrobial agents. This review is focused on the current knowledge of porins and efflux pump(s) in this microorganism.
Similar articles
-
[Multi-drug efflux pumps and antibiotic resistance in Acinetobacter baumannii].Rev Chilena Infectol. 2009 Dec;26(6):499-503. Epub 2009 Dec 21. Rev Chilena Infectol. 2009. PMID: 20098782 Review. Spanish.
-
Treatment of multiresistant Acinetobacter baumannii infections.Curr Opin Investig Drugs. 2009 Feb;10(2):150-6. Curr Opin Investig Drugs. 2009. PMID: 19197792 Review.
-
[The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria].Mikrobiyol Bul. 2007 Apr;41(2):309-27. Mikrobiyol Bul. 2007. PMID: 17682720 Review. Turkish.
-
Distribution of the multidrug efflux pump genes, adeABC, adeDE and adeIJK, and class 1 integron genes in multiple-antimicrobial-resistant clinical isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus complex.Int J Antimicrob Agents. 2009 Jan;33(1):27-32. doi: 10.1016/j.ijantimicag.2008.06.027. Epub 2008 Sep 13. Int J Antimicrob Agents. 2009. PMID: 18790612
-
Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.J Antimicrob Chemother. 2008 Sep;62(3):484-9. doi: 10.1093/jac/dkn205. Epub 2008 May 13. J Antimicrob Chemother. 2008. PMID: 18477708
Cited by
-
Colony phase variation switch modulates antimicrobial tolerance and biofilm formation in Acinetobacter baumannii.Microbiol Spectr. 2024 Feb 6;12(2):e0295623. doi: 10.1128/spectrum.02956-23. Epub 2024 Jan 11. Microbiol Spectr. 2024. PMID: 38205963 Free PMC article.
-
Mutations Decreasing Intrinsic β-Lactam Resistance Are Linked to Cell Division in the Nosocomial Pathogen Acinetobacter baumannii.Antimicrob Agents Chemother. 2016 May 23;60(6):3751-8. doi: 10.1128/AAC.00361-16. Print 2016 Jun. Antimicrob Agents Chemother. 2016. PMID: 27067318 Free PMC article.
-
First report of colistin resistance among carbapenem-resistant Acinetobacter baumannii isolates recovered from hospitalized patients in Egypt.New Microbes New Infect. 2018 Aug 24;26:53-58. doi: 10.1016/j.nmni.2018.08.007. eCollection 2018 Nov. New Microbes New Infect. 2018. PMID: 30224972 Free PMC article.
-
The frequency of efflux pump genes expression in Acinetobacter baumannii isolates from pulmonary secretions.AMB Express. 2022 Aug 4;12(1):103. doi: 10.1186/s13568-022-01444-4. AMB Express. 2022. PMID: 35925415 Free PMC article.
-
Whole-Genome Sequences of Five Acinetobacter baumannii Strains From a Child With Leukemia M2.Front Microbiol. 2019 Feb 6;10:132. doi: 10.3389/fmicb.2019.00132. eCollection 2019. Front Microbiol. 2019. PMID: 30787915 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources